NCT05745909Completed
Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy
Randomized Single Center Clinical Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy in Patients After Major Anterior Resections
Source: ClinicalTrials.gov · Last updated 19 Sept 2024
Brief summary (registry, in English)
The purpose of this study is to determine which stoma creation technique is preferable after low anterior resection of the rectum.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 150 (actual)
- First submitted
- 4 Feb 2023
- Start date
- 1 Mar 2023
- Primary completion date
- 31 May 2024
- Lead sponsor
- Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan
- Diseases
- Colorectal cancer
- NCT number
- NCT05745909
What you commit to
- Study type: Interventional
- Participants enrolled: 150
- From 1 Mar 2023 to the primary completion date, 31 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Emergency surgery;
- Previously formed stoma;
- Obstructive resection of the rectum;
Other illness
- Stage 4 disease;
Age
- Patients older than 79 years
Who the study is looking for
- Histologically confirmed adenocarcinoma of the rectum (stages 1-3 according to MRI)
- ECOG status 0-2,
- ASA≤3.
- At least 18 years of age
- Written informed consent
Age in the registry: 18 years to 79 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Republican clinical oncological dispencery Coordinator of this site? Confirm its status | Ufa | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.